"Generic Prozac is a nice, large onetime cash generator, but Barr has assembled a very strong near-term product lineup that is going to continue to drive an accelerating growth profile over the next couple of years, " says Elliot Wilbur, specialty pharmaceuticals analyst at CIBC Oppenheimer.